GSK Augmentin ES Needs "Boundary" On Resistant Strains Covered, FDA Cmte

GlaxoSmithKline should indicate an upper "boundary" of penicillin resistance that its antibiotic Augmentin ES is expected to effectively treat, FDA's Anti-Infective Drugs Advisory Committee suggested Jan. 30.